SPOTLIGHT: Pharmacopeia teams with Allergan

Pharmacopeia and Irvine, California-based Allergan will collaborate in researching compounds for age-related macular degeneration. "We are working with Allergan to investigate alternate mechanistic approaches that could complement or potentially improve upon existing therapies," said Dr. David M. Floyd, chief scientific officer of Pharmacopeia. Release

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.